Magnetic resonance imaging of melanoma metastases in a clinical relevant human melanoma xenograft scid mouse model

Cancer Letters

Volumn 274, Issue 2, 2009, Pages 194-200

  Thies, Anka ^a   Peldschus, Kersten ^a   Ittrich, Harald ^a   Adam, Gerhard ^a   Altevogt, Peter ^b   Wagener, Christoph ^a   Schumacher, Udo ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

CEACAM1; HPA; L1; Melanoma metastasis; MRI

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; CARCINOEMBRYONIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; MALE; MELANOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MICE; MICE, SCID; NEOPLASM METASTASIS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 58149466455     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.09.011     Document Type: Article

References (26)

1. Lens M.B., and Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br. J. Dermatol. 150 (2004) 179-185
2. Schumacher U., and Adam E. Lectin histochemical HPA-binding pattern of human breast and colon cancers is associated with metastasis formation in severe combined immunodeficient mice. Histochem. J. 29 (1997) 677-684
3. Thies A., Dautel P., Meyer A., Pfüller U., and Schumacher U. Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model. Br. J. Cancer 98 (2008) 106-112
4. Thies A., Mauer S., Fodstad O., and Schumacher U. Clinically proven markers of metastasis predict spread of human melanoma cells engrafted in scid mice. Br. J. Cancer 96 (2007) 609-616
5. Garbe C.T., Hauschild A.T., Volkenandt M.T., Schadendorf D.T., Stolz W.T., Reinhold U.T., Kortmann R.D.T., Kettelhack C.T., Frerich B.T., Keilholz U.T., Dummer R.T., and Sebastian G.T. Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res. 18 (2008) 61-67
6. Koo V., Hamilton P.W., and Williamson K. Non-invasive in vivo imaging in small animal research. Cell. Oncol. 28 (2006) 127-139
7. Moats R., Ma L.Q., Wajed R., Sugiura Y., Lazaryev A., Tyszka M., Jacobs R., Fraser S., Nelson Jr. M.D., and DeClerck Y.A. Magnetic resonance imaging for the evaluation of a novel metastatic orthotopic model of human neuroblastoma in immunodeficient mice. Clin. Exp. Metast. 18 (2000) 455-461
8. Thies A., Moll I., Berger J., and Schumacher U. Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation. Br. J. Cancer 84 (2001) 819-823
9. Thies A., Moll I., Berger J., Wagener C., Brümmer J., Schulze H.-J., Brunner G., and Schumacher U. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J. Clin. Oncol. 20 (2002) 2530-2536
10. Thies A., Schachner M., Moll I., Berger J., Schulze H.-J., Brunner G., and Schumacher U. Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur. J. Cancer 38 (2002) 1708-1716
11. Thies A., Berlin A., Brunner G., Schulze H.-J., Moll I., Pfüller U., Wagener C., Schachner M., Altevogt P., and Schumacher U. Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases. Cancer Lett. 248 (2007) 68-80
12. Edward M. Melanoma cell-derived factors stimulate glycosaminoglycan synthesis by fibroblast cultured as monolayers and within contracted collagen lattices. Br. J. Dermatol. 144 (2001) 465-470
13. Workman P., Twentyman P., Balkwill F., Balmain A., Chaplin D., Double J., Embleton J., Newell D., Raymond R., Stables J., Stephens T., and Wallace J. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition). Br. J. Cancer 77 (1997) 1-10
14. Jojovic M., and Schumacher U. Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer cells transplanted into SCID mice. Cancer Lett. 152 (2000) 151-156
15. Valentiner U., Hall D.B.S., Brooks S.A., and Schumacher U. HPA binding and metastasis formation of human breast cancer cell lines transplanted into severe combined immunodeficient (scid) mice. Cancer Lett. 219 (2005) 233-242
16. Kjonniksen I., Rye P.D., and Fodstad O. Helix pomatia agglutinin in human tumour cell lines: correlation with pulmonary metastases in nude mice. Br. J. Cancer 69 (1994) 1021-1024
17. De Giorgi V., Massi D., Germini G., Mannone F., Quercioli E., and Carli P. Immediate local recurrence after the excision of a polypoid melanoma: tumor dormancy or tumor activation?. Dermatol. Surg. 29 (2003) 664-667
18. Ebrahimnejad A., Streichert T., Nollau P., Horst A.K., Wagener C., Bamberger A.M., and Brummer J. CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am. J. Pathol. 165 (2004) 1781-1787
19. Gutwein P., Mechtersheimer S., Riedle S., Stoeck A., Gast D., Joumaa S., Zentgraf H., Fogel M., and Altevogt P. TADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J. 17 (2003) 292-294
20. Voura E.B., Ramjeesingh R.A., Montgomery A.M., and Siu C.H. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol. Biol. Cell 12 (2001) 2699-2710
21. Ergün S., Kilik N., Ziegeler G., Hansen A., Nollau P., Gotze J., Wurmbach J.H., Horst A., Weil F., Fernando M., and Wagener C. CEA-related cell adhesion molecule 1: a potent angiogenic factor and major effector of vascular endothelial growth factor. Mol. Cell 5 (2000) 311-320
22. Schumacher U., Brooks S.A., and Mester J. The lectin Helix pomatia agglutinin as a marker of metastases- clinical and experimental studies. Anticancer Res. 25 (2005) 829-1830
23. Lejeune F.J. The impact of surgery on the course of melanoma. Recent Results Cancer Res. 160 (2002) 151-157
24. Garbow J.R., Wang M., Wang Y., Lubet R.A., and You M. Quantitative monitoring of adenocarcinoma development in rodents by magnetic resonance imaging. Clin. Cancer Res. 14 (2008) 1363-1367
25. Bankson J.A., Ji L., Ravoori M., Han L., and Kundra V. Echo-planar imaging for MRI evaluation of intrathoracic tumors in murine models of lung cancer. J. Magn. Reson. Imag. 27 (2008) 57-62
26. Freudlsperger C., Thies A., Pfüller U., and Schumacher U. The proteasome inhibitor bortezomib augments anti-proliferative effects of mistletoe lectin-I and the PPAR-gamma agonist rosiglitazone in human melanoma cells. Anticancer Res. 27 (2007) 207-213